Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Regan Fulton"'
Autor:
Myrto Moutafi, Charles J. Robbins, Vesal Yaghoobi, Aileen I. Fernandez, Sandra Martinez-Morilla, Vasiliki Xirou, Yalai Bai, Yan Song, Patricia Gaule, Joseph Krueger, Kenneth Bloom, Salisha Hill, Daniel C. Liebler, Regan Fulton, David L. Rimm
Publikováno v:
Laboratory Investigation. 102:1101-1108
The efficacy of the antibody drug conjugate (ADC) Trastuzumab deruxtecan (T-DXd) in HER2 low breast cancer patients suggests that the historical/conventional assays for HER2 may need revision for optimal patient care. Specifically, the conventional a
Autor:
Regan Fulton, Saba Shafi, Jonathan Warrell, Yalai Bai, Mark Gerstein, Ioannis A. Vathiotis, David L. Rimm, Patricia Gaule, Thazin Nwe Aung, Balazs Acs, Myrto Moutafi, Sandra Martinez-Morilla, Benjamin Freiberg
Publikováno v:
Mod Pathol
Ki67, a nuclear proliferation-related protein, is heavily used in anatomic pathology but has not become a companion diagnostic or a standard-of-care biomarker due to analytic variability in both assay protocols and interpretation. The International K
Autor:
Regan Fulton
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 29(2)
Autor:
Thomas J. Long, Tatjana Antic, Masha Kocherginsky, Maria S. Tretiakova, Regan Fulton, Allen M. Gown, Cigdem Ussakli
Publikováno v:
Modern Pathology. 31:623-632
Therapy with anti-PD-L1 immune check-point inhibitors is approved for several cancers, including advanced urothelial carcinomas. PD-L1 prevalence estimates vary widely in bladder cancer, and lack of correlation between expression and clinical outcome
Autor:
Thomas A. Summers, Patti A. Loykasek, Jeff Goldsmith, Dylan V. Miller, Kurt B. Schaberg, Yaping Wu, Dennis P. O'Malley, Jinru Shia, Abiy B. Ambaye, Robert A. Schwartz, Jingxin Qiu, Paul E. Swanson, Andrew M. Bellizzi, Megan L. Troxell, Thomas Haas, Regan Fulton, Patrick L. Fitzgibbons, Mohamed E. Salama
Publikováno v:
Archives of Pathology & Laboratory Medicine. 143:907-909
Autor:
Pankaj Oberoi, Danielle Fernando, Andrew Z. Milinichik, Elizabeth B. Somers, Earl Albone, Brian E. Tomkowicz, Xin Cheng, Young Chul Park, Daniel J. O'Shannessy, Regan Fulton, Michael F. Smith, Stephen M. Jackson, Nicholas C. Nicolaides, Brad Kline
Publikováno v:
Oncotarget
// Daniel J. O’Shannessy 1 , Michael F. Smith 1 , Elizabeth B. Somers 1 , Stephen M. Jackson 1 , Earl Albone 1 , Brian Tomkowicz 1 , Xin Cheng 1 , Young Park 1 , Danielle Fernando 1 , Andrew Milinichik 1 , Brad Kline 1 , Regan Fulton 2 , Pankaj Obe
Autor:
Parveen Shiraz, Angela M. Capra, Regan Fulton, Laurel A. Habel, Louis Fehrenbacher, Charles P. Quesenberry
Publikováno v:
Journal of Clinical Oncology. 32:2151-2158
Purpose To determine the invasive recurrence (IR) risk among patients with small, node-negative human epidermal growth factor receptor 2 (HER2) –positive breast cancer. Patients and Methods Among 16,975 consecutive patients with invasive breast can
Autor:
Mogens Vyberg, Molecular Morphology, Carol C. Cheung, Keith W. Miller, Manfred Dietel, Glenn Francis, Paul E. Swanson, Corrado D'Arrigo, Xiaoge Zhou, Merdol Ibrahim, Antonio Marchetti, Clive R. Taylor, Emina Torlakovic, C. Blake Gilks, J. Han van Krieken, Regan Fulton, Jason L. Hornick, Jacqueline A Hall, Søren Nielsen
Publikováno v:
Cheung, C C, D'Arrigo, C, Dietel, M, Francis, G D, Fulton, R, Gilks, C B, Hall, J A, Hornick, J L, Ibrahim, M, Marchetti, A, Miller, K, van Krieken, J H, Nielsen, S, Swanson, P E, Taylor, C R, Vyberg, M, Zhou, X, Torlakovic, E E & From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path) 2017, ' Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine : Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry ', Applied Immunohistochemistry & Molecular Morphology, vol. 25, no. 4, pp. 227-230 . https://doi.org/10.1097/PAI.0000000000000469
The numbers of diagnostic, prognostic, and predictive immunohistochemistry (IHC) tests are increasing; the implementation and validation of new IHC tests, revalidation of existing tests, as well as the on-going need for daily quality assurance monito
Publikováno v:
Histopathology. 68(1)
This review summarizes the three major breast-associated markers that can be of assistance in evaluating metastatic carcinomas for which a breast primary diagnosis is entertained. These markers include gross cystic disease fluid protein-15 (GCDFP-15)
Autor:
Roger A. Warnke, Regan Fulton, Youn H. Kim, Uma Sundram, Richard T. Hoppe, Ingerlisa W. Mattoch
Publikováno v:
American Journal of Clinical Pathology. 131:810-819
Although the new World Health Organization-European Organization for Research and Treatment of Cancer classification focuses on providing uniformity in the diagnosis of cutaneous lymphomas, cutaneous peripheral T-cell lymphoma (PTL) remains a poorly